Evidence for Hexagonal II Phase Lipid Involvement in Mitochondrial Ca2+ Movements

  • Paul Wolkowicz
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 232)


The release of matrix Ca2+ from mitochondria is induced by a variety of compounds, eg. palmitoyl-CoA (P-CoA) (1). Addition of these compounds to mitochondria which contain Ca2+ produces a period of mitochondrial Ca2+ release and reaccumulation, i.e. Ca2+ cycling, followed by large amplitude swelling, inner membrane depolarization and net Ca2+ release (2). These phenomena occur only if inorganic phosphate is in the reaction medium (3). Whether these observations are related to the mechanism(s) through which the mitochondrion contributes to Ca2+ homeostasis in the normal cell remains to be determined. However, under pathological conditions such as ischemia this process of Ca2+ release may relate to matrix Ca2+ content and mitochondrial volume changes observed (4).


Butylate Hydroxy Toluene Lower Trace Release Agent Isatoic Anhydride Downward Deflection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. (1.
    Asimakis, G.R. and Sordahl, L.A. (1977) Arch. Biochem. Biophys. 179, 200–210.PubMedCrossRefGoogle Scholar
  2. (2.
    Wolkowicz, P.E. and McMillin-Wood, J.B. (1980) Biochem. J. 186, 257–266.PubMedGoogle Scholar
  3. (3.
    Wolkowicz, P.E. and McMillin-Wood, J.B. (1980) J. Biol. Chem. 255, 10348–10353.PubMedGoogle Scholar
  4. (4.
    Henry, P.D., Shuchleib, R., Davis, J., Weiss, S. and Sobel, B.E. (1977) Am. J. Physiol. 233, H677–684.PubMedGoogle Scholar
  5. (5.
    Jung, D.W. and Brierly, G.P. (1981) J. Biol. Chem. 256, 10490–10496.PubMedGoogle Scholar
  6. (6.
    Nakashima, R.A., Dordick, R.S. and Garlid, R.D. (1982) J. Biol. Chem. 257, 12540–12545.PubMedGoogle Scholar
  7. (7.
    Beatrice, M.D., Palmer, J.W. and Pfeiffer, D.R. (1980) J. Biol. Chem. 8663–8669.Google Scholar
  8. (8.
    Leung, H.W., Vang, M.J. and Mavis, R.D. (1981) Biochem. Biophys. Acta 664, 266–272.PubMedCrossRefGoogle Scholar
  9. (9.
    Wolkowicz, P.E. and McMillin-Wood, J.B. (1981) Arch. Biochem. Biophys. 209, 408–422.PubMedCrossRefGoogle Scholar
  10. (10.
    Reynafarje, B. and Lehninger, A.L. (1977) Biochem. Biophys. Res. Commun. 77, 1273–1279.PubMedCrossRefGoogle Scholar
  11. (11.
    Bardsley, M.E. and Brand, M.D. (1982) Biochem. J. 202, 197–201.PubMedGoogle Scholar
  12. (12.
    Coty, W.A. and Pedersen, P.L. (1975) Mol. and Cell. Biochem. 9, 109–124.CrossRefGoogle Scholar
  13. (13.
    Sokolove, P.M. and Shinaberry, R.G. (1986) Biophys. J. 49, 94a.CrossRefGoogle Scholar
  14. (14.
    Cheng, K.H., Yeagle, P.L., Lepock, J.R. and Hui, S.W. (1986) Biophys. J. 49, 324a.Google Scholar
  15. (15.
    Moorman, A.R. and Abeus, R.H. (1982) J. Amer. Chem. Soc. 104, 6785–6788.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Paul Wolkowicz
    • 1
  1. 1.Department of Medicine Division of Cardiovascular DiseaseUniversity of Alabama School of Medicine at BirminghamBirminghamUSA

Personalised recommendations